Enhanced Silkworm Cecropin B Antimicrobial Activity against Pseudomonas aeruginosa from Single Amino Acid Variation
Related Experiment Video
Updated: Jan 25, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Ottavia Romoli1, Shruti Mukherjee2, Sk Abdul Mohid2
1Department of Biology , University of Padova , Via Ugo Bassi 58/B , 35131 Padova , Italy.
Abstract:
Pseudomonas aeruginosa is an opportunistic bacterial pathogen causing severe infections in hospitalized and immunosuppressed patients, particularly individuals affected by cystic fibrosis. Several clinically isolated P. aeruginosa strains were found to be resistant to three or more antimicrobial classes indicating the importance of identifying new antimicrobials active against this pathogen. Here, we characterized the antimicrobial activity and the action mechanisms against P. aeruginosa of two natural isoforms of the antimicrobial peptide cecropin B, both isolated from the silkworm Bombyx mori. These cecropin B isoforms differ in a single amino acid substitution within the active portion of the peptide, so that the glutamic acid of the E53 CecB variant is replaced by a glutamine in the Q53 CecB isoform. Both peptides showed a high antimicrobial and membranolytic activity against P. aeruginosa, with Q53 CecB displaying greater activity compared with the E53 CecB isoform. Biophysical analyses, live-cell NMR, and molecular-dynamic-simulation studies indicated that both peptides might act as membrane-interacting elements, which can disrupt outer-membrane organization, facilitating their translocation toward the inner membrane of the bacterial cell. Our data also suggest that the amino acid variation of the Q53 CecB isoform represents a critical factor in stabilizing the hydrophobic segment that interacts with the bacterial membrane, determining the highest antimicrobial activity of the whole peptide. Its high stability to pH and temperature variations, tolerance to high salt concentrations, and low toxicity against human cells make Q53 CecB a promising candidate in the development of CecB-derived compounds against P. aeruginosa.
Insights
Two cecropin B isoforms from silkworms show potent antimicrobial activity against Pseudomonas aeruginosa. The Q53 CecB variant exhibits superior efficacy due to enhanced membrane interaction, offering a promising new therapeutic candidate.
Area of Science:
- Microbiology
- Biochemistry
- Biophysics
Background:
- Pseudomonas aeruginosa infections pose a significant threat, especially in vulnerable populations like cystic fibrosis patients.
- Increasing antimicrobial resistance in P. aeruginosa necessitates the discovery of novel therapeutic agents.
- Antimicrobial peptides (AMPs) represent a promising class of compounds for combating resistant bacterial strains.
Purpose of the Study:
- To investigate the antimicrobial activity and mechanisms of two cecropin B (CecB) isoforms from Bombyx mori against Pseudomonas aeruginosa.
- To compare the efficacy of the E53 CecB and Q53 CecB isoforms, which differ by a single amino acid substitution.
- To elucidate the molecular interactions underlying the antimicrobial action of these CecB variants.
Main Methods:
- Antimicrobial susceptibility testing and membrane-disruption assays were performed.
- Biophysical analyses, including live-cell Nuclear Magnetic Resonance (NMR), were utilized.
- Molecular dynamics simulations were employed to study peptide-membrane interactions.
Main Results:
- Both E53 CecB and Q53 CecB demonstrated significant antimicrobial and membranolytic activity against P. aeruginosa.
- The Q53 CecB isoform exhibited greater antimicrobial potency than the E53 CecB isoform.
- Studies indicated that both peptides disrupt the bacterial outer membrane, facilitating translocation to the inner membrane, with Q53 CecB showing enhanced membrane interaction and stability.
Conclusions:
- The single amino acid variation in Q53 CecB is crucial for its enhanced antimicrobial activity against P. aeruginosa.
- Q53 CecB displays favorable properties, including stability and low human cell toxicity, making it a promising lead for developing new anti-P. aeruginosa therapeutics.
- Cecropin B isoforms represent a viable strategy for developing novel antimicrobial compounds against challenging bacterial pathogens.
Related Concept Videos
Amino acids
Amino Acid Catabolism
Amino Acid Biosynthetic Pathways
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
What is Variation?
The range, standard deviation, standard error, and variance are the different measures of variation.
Range: The range is the difference between its maximum and...
tRNA Activation

